ES2645643T3 - Derivado de benzodioxol y método de preparación y uso de los mismos - Google Patents
Derivado de benzodioxol y método de preparación y uso de los mismos Download PDFInfo
- Publication number
- ES2645643T3 ES2645643T3 ES13813363.2T ES13813363T ES2645643T3 ES 2645643 T3 ES2645643 T3 ES 2645643T3 ES 13813363 T ES13813363 T ES 13813363T ES 2645643 T3 ES2645643 T3 ES 2645643T3
- Authority
- ES
- Spain
- Prior art keywords
- ethyl
- dioxolo
- piperidyl
- isoindole
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210226125.7A CN103524515B (zh) | 2012-07-03 | 2012-07-03 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
| CN201210226125 | 2012-07-03 | ||
| PCT/CN2013/000813 WO2014005421A1 (zh) | 2012-07-03 | 2013-07-03 | 苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2645643T3 true ES2645643T3 (es) | 2017-12-07 |
Family
ID=49881293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13813363.2T Active ES2645643T3 (es) | 2012-07-03 | 2013-07-03 | Derivado de benzodioxol y método de preparación y uso de los mismos |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9346818B2 (https=) |
| EP (1) | EP2871184B1 (https=) |
| JP (1) | JP6113275B2 (https=) |
| KR (1) | KR101650776B1 (https=) |
| CN (2) | CN103524515B (https=) |
| AU (1) | AU2013286523B2 (https=) |
| BR (1) | BR112014032964A2 (https=) |
| CA (1) | CA2878000C (https=) |
| CL (1) | CL2014003607A1 (https=) |
| DK (1) | DK2871184T3 (https=) |
| EA (1) | EA026210B1 (https=) |
| ES (1) | ES2645643T3 (https=) |
| IL (1) | IL236395A (https=) |
| IN (1) | IN2014DN11112A (https=) |
| MX (1) | MX357774B (https=) |
| MY (1) | MY167075A (https=) |
| NO (1) | NO2871184T3 (https=) |
| NZ (1) | NZ703549A (https=) |
| PE (1) | PE20150349A1 (https=) |
| PH (1) | PH12015500012A1 (https=) |
| PT (1) | PT2871184T (https=) |
| SG (1) | SG11201500007WA (https=) |
| UA (1) | UA113444C2 (https=) |
| WO (1) | WO2014005421A1 (https=) |
| ZA (1) | ZA201500692B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103524515B (zh) * | 2012-07-03 | 2016-07-06 | 浙江海正药业股份有限公司 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
| CN105859732B (zh) * | 2016-04-11 | 2018-04-06 | 浙江海正药业股份有限公司 | 制备ad‑35的工艺 |
| US11129822B2 (en) * | 2016-05-13 | 2021-09-28 | DelNova, Inc. | Treating of side-effects resulting from chemodenervation |
| CN110812358B (zh) * | 2018-08-10 | 2022-04-05 | 浙江海正药业股份有限公司 | 化合物ad-35在治疗与胃肠蠕动障碍相关疾病中的应用 |
| CN113185447B (zh) * | 2021-05-06 | 2023-07-21 | 四川大学 | 邻苯二甲酰半胱酰胺类化合物、其制备方法和用途 |
| CN115974839B (zh) * | 2021-12-24 | 2023-10-20 | 珠海市藤栢医药有限公司 | AChE/SERT双靶点抑制剂及其制备方法和用途 |
| CN120172986A (zh) * | 2023-12-19 | 2025-06-20 | 浙江海正药业股份有限公司 | Ad-35多晶型物及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4087541A (en) * | 1975-03-06 | 1978-05-02 | Boehringer Ingelheim Gmbh | 2-(Aralkylaminoalkyl)phthalimidines |
| US5175157A (en) * | 1985-11-27 | 1992-12-29 | Boehringer Ingelheim Gmbh | Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JPH0610496B2 (ja) * | 1987-09-17 | 1994-02-09 | ダイハツ工業株式会社 | 車両用自動変速機のクラッチ構造 |
| JP2777159B2 (ja) * | 1988-12-22 | 1998-07-16 | エーザイ株式会社 | 環状アミン誘導体を含有する医薬 |
| IL125809A (en) | 1998-08-17 | 2005-08-31 | Finetech Lab Ltd | Process and intermediates for production of donepezil and related compounds |
| US7166617B2 (en) | 2000-02-29 | 2007-01-23 | Mitsubishi Pharma Corporation | Cyclic amide derivatives |
| US20050107432A1 (en) * | 2002-01-22 | 2005-05-19 | Yoichi Iimura | Sigma receptor binder containing indanone derivative |
| US7446203B2 (en) | 2003-07-01 | 2008-11-04 | Hetero Drugs Limited | Preparation of intermediates for acetycholinesterase inhibitors |
| WO2005076749A2 (en) | 2004-02-11 | 2005-08-25 | Jubilant Organosys Limited | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine |
| NZ569532A (en) | 2006-01-04 | 2010-11-26 | Cipla Ltd | Process and intermediate for preparation of donepezil |
| AU2007207149A1 (en) | 2006-01-18 | 2007-07-26 | Siena Biotech S.P.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| AU2007333586A1 (en) * | 2006-12-11 | 2008-06-19 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors |
| CN103524515B (zh) * | 2012-07-03 | 2016-07-06 | 浙江海正药业股份有限公司 | 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途 |
-
2012
- 2012-07-03 CN CN201210226125.7A patent/CN103524515B/zh active Active
-
2013
- 2013-03-07 UA UAA201500866A patent/UA113444C2/uk unknown
- 2013-07-03 IN IN11112DEN2014 patent/IN2014DN11112A/en unknown
- 2013-07-03 EA EA201590074A patent/EA026210B1/ru not_active IP Right Cessation
- 2013-07-03 MY MYPI2014704095A patent/MY167075A/en unknown
- 2013-07-03 CN CN201380033665.6A patent/CN104395303B/zh active Active
- 2013-07-03 EP EP13813363.2A patent/EP2871184B1/en active Active
- 2013-07-03 SG SG11201500007WA patent/SG11201500007WA/en unknown
- 2013-07-03 NO NO13813363A patent/NO2871184T3/no unknown
- 2013-07-03 US US14/411,783 patent/US9346818B2/en active Active
- 2013-07-03 WO PCT/CN2013/000813 patent/WO2014005421A1/zh not_active Ceased
- 2013-07-03 JP JP2015518794A patent/JP6113275B2/ja active Active
- 2013-07-03 CA CA2878000A patent/CA2878000C/en active Active
- 2013-07-03 BR BR112014032964A patent/BR112014032964A2/pt not_active Application Discontinuation
- 2013-07-03 MX MX2015000334A patent/MX357774B/es active IP Right Grant
- 2013-07-03 AU AU2013286523A patent/AU2013286523B2/en active Active
- 2013-07-03 NZ NZ703549A patent/NZ703549A/en not_active IP Right Cessation
- 2013-07-03 ES ES13813363.2T patent/ES2645643T3/es active Active
- 2013-07-03 DK DK13813363.2T patent/DK2871184T3/da active
- 2013-07-03 PE PE2014002581A patent/PE20150349A1/es active IP Right Grant
- 2013-07-03 PT PT138133632T patent/PT2871184T/pt unknown
- 2013-07-03 KR KR1020157002550A patent/KR101650776B1/ko not_active Expired - Fee Related
-
2014
- 2014-12-22 IL IL236395A patent/IL236395A/en not_active IP Right Cessation
- 2014-12-31 CL CL2014003607A patent/CL2014003607A1/es unknown
-
2015
- 2015-01-05 PH PH12015500012A patent/PH12015500012A1/en unknown
- 2015-01-30 ZA ZA2015/00692A patent/ZA201500692B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2645643T3 (es) | Derivado de benzodioxol y método de preparación y uso de los mismos | |
| ES2897913T3 (es) | Compuestos de piridona tetracíclicos como antivirales | |
| ES2852753T3 (es) | Compuestos espirocíclicos como agonistas del receptor muscarínico M1 y/o M4 | |
| EP3860989B1 (en) | Fused pyrrolines which act as ubiquitin-specific protease 30 (usp30) inhibitors | |
| CA2918217C (fr) | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ES2898206T3 (es) | Compuestos heterocíclicos que tienen actividad como moduladores de los receptores muscarínicos M1 y/o M4 en el tratamiento de enfermedades y dolores del SNC | |
| AU2021200164B2 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| ES3007998T3 (en) | Opioid receptor modulators | |
| ES2264078T3 (es) | Derivados de benzofurano para incrementar las respuestas sinapticas glutamatergicas. | |
| PT2356123E (pt) | Espiro-5,6-di-hidro-4h-2,3,5,10b-tetra-azabenzo[ e]azulenos | |
| JP6186440B2 (ja) | キナーゼ阻害剤としてのジヒドロピロリジノピリミジン | |
| TW201118069A (en) | Spirolactam derivatives and uses of same | |
| CA3241298A1 (en) | Antagonists of the muscarinic acetylcholine receptor m4 | |
| ES2706475T3 (es) | Nuevos derivados de bencimidazol como agentes antihistamínicos | |
| JP2022546410A (ja) | Ｐｅｒｋ阻害化合物 | |
| ES2602193T3 (es) | 7-metil-2-[4-metil-6-[4-(trifluorometil)-fenil]pirimidin-2-il]-1,7-diazaespiro[4.4]nonan-6-ona | |
| JPWO2008108309A1 (ja) | 縮環ピリジン誘導体 | |
| EP3759085B1 (en) | Substituted cyclohexyl compounds as nop inhibitors | |
| RU2800292C2 (ru) | Химические соединения | |
| WO2025072437A1 (en) | Heteroaryl compounds and their use in treating medical conditions | |
| HK1202857B (en) | Benzodioxole derivative and preparation method and use thereof | |
| WO2026061104A1 (zh) | 用于雄激素受体靶向降解的化合物和方法 |